Found: 19
Select item for more details and to access through your institution.
Inhibitor development: patient-determined risk factors.
- Published in:
- 2010
- By:
- Publication type:
- Report
The disappearing act of factor VIII.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 6, doi. 10.1111/j.1365-2516.2008.01864.x
- By:
- Publication type:
- Article
Diagnosis and treatment of acquired haemophilia.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 102, doi. 10.1111/j.1365-2516.2010.02232.x
- By:
- Publication type:
- Article
HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 44, doi. 10.1111/j.1365-2516.2008.01905.x
- By:
- Publication type:
- Article
The relevance of the bleeding severity in the treatment of acquired haemophilia – an update of a single-centre experience with 67 patients.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 95, doi. 10.1111/j.1365-2516.2008.01922.x
- By:
- Publication type:
- Article
Diagnosis and quantification of factor VIII inhibitors.
- Published in:
- 2010
- By:
- Publication type:
- Report
Modulation of factor VIII-specific memory B cells.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 25, doi. 10.1111/j.1365-2516.2008.01962.x
- By:
- Publication type:
- Article
HLA genotype in patients with acquired haemophilia A.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 107, doi. 10.1111/j.1365-2516.2008.01976.x
- By:
- Publication type:
- Article
Gene therapy for immunological tolerance: using ‘transgenic’ B cells to treat inhibitor formation.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 89, doi. 10.1111/j.1365-2516.2010.02203.x
- By:
- Publication type:
- Article
Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 84, doi. 10.1111/j.1365-2516.2010.02223.x
- By:
- Publication type:
- Article
Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 35, doi. 10.1111/j.1365-2516.2010.02215.x
- By:
- Publication type:
- Article
Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 71, doi. 10.1111/j.1365-2516.2010.02225.x
- By:
- Publication type:
- Article
Role of anti-idiotypic antibodies in immune tolerance induction.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 80, doi. 10.1111/j.1365-2516.2010.02226.x
- By:
- Publication type:
- Article
Autoantibodies to coagulation factors.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 56, doi. 10.1111/j.1365-2516.2010.02229.x
- By:
- Publication type:
- Article
Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 16, doi. 10.1111/j.1365-2516.2010.02233.x
- By:
- Publication type:
- Article
Inhibitors in previously treated patients: a review of the literature.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 61, doi. 10.1111/j.1365-2516.2010.02235.x
- By:
- Publication type:
- Article
Commentary on Brackmann and Gormsen ( Lancet 1977; ii: 933): Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 4, doi. 10.1111/j.1365-2516.2010.02237.x
- By:
- Publication type:
- Article
Massive factor-VIII infusion in Hæmophiliac with factor-VIII inhibitor, high responder.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 2, doi. 10.1111/j.1365-2516.2010.02266.x
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Haemophilia, 2010, v. 16, n. 102, p. 1, doi. 10.1111/j.1365-2516.2010.02274.x
- By:
- Publication type:
- Article